Quantifying tumor evolutionary dynamics and predictors of response in HER2-positive breast cancer treated with targeted therapy

Placeholder Show Content

Abstract/Contents

Abstract
Evolution during treatment is a significant clinical problem that leads to treatment failure, resistance, and disease progression in many solid tumors, including breast cancer. Through analysis of clinical tissue samples and using a combination of established genomic techniques, computational modeling, and novel molecular profiling methods, this dissertation explores how HER2-positive breast tumors evolve under systemic therapy and characterizes predictors of treatment response. First using multi-region genomic sequencing and computational modeling, we show that the mutational landscape of a tumor can shift dramatically over a few months of combination chemotherapy and HER2-targeted therapy (termed "clonal replacement"). We then utilized tissue from a neoadjuvant HER2-positive breast cancer clinical trial to explore tumor-associated and immune-associated predictors of treatment response. We demonstrate the utility of spatial proteomic analysis of on-treatment biopsies to define biomarkers that stratify sensitive tumors early during neoadjuvant HER2-targeted therapy with implications for tailoring subsequent therapy. Taken together, our results shed light on the roles of heterogeneity, the frequency of resistance-causing aberrations, and the immune microenvironment in response to HER2-targeted therapy. In addition, our results also provide insights into the design of clinical trials that have a molecular analysis component

Description

Type of resource text
Form electronic resource; remote; computer; online resource
Extent 1 online resource
Place California
Place [Stanford, California]
Publisher [Stanford University]
Copyright date 2020; ©2020
Publication date 2020; 2020
Issuance monographic
Language English

Creators/Contributors

Author McNamara, Katherine Lee
Degree supervisor Curtis, Christina
Thesis advisor Curtis, Christina
Thesis advisor Altman, Russ
Thesis advisor Petrov, Dmitri Alex, 1969-
Thesis advisor Sage, Julien
Thesis advisor West, Robert
Degree committee member Altman, Russ
Degree committee member Petrov, Dmitri Alex, 1969-
Degree committee member Sage, Julien
Degree committee member West, Robert
Associated with Stanford University, Cancer Biology Program.

Subjects

Genre Theses
Genre Text

Bibliographic information

Statement of responsibility Katherine Lee McNamara
Note Submitted to the Cancer Biology Program
Thesis Thesis Ph.D. Stanford University 2020
Location electronic resource

Access conditions

Copyright
© 2020 by Katherine Lee McNamara
License
This work is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported license (CC BY-NC).

Also listed in

Loading usage metrics...